Mannose-targeted iguratimod liposomes in an HA-derived hydrogel: a synergistic therapy for rheumatoid arthritis via macrophage targeting and ROS scavenging
Biomaterials Science · 2026 · 14 (22) · 5912-5926
DOI: 10.1039/d6bm00740f ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Jun Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 210009, China. geliang@cpu.edu.cn. Hauptthemen laut MEDLINE: Macrophages, Hydrogels, Arthritis, Rheumatoid, Reactive Oxygen Species. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and irreversible joint damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 210009, China. geliang@cpu.edu.cn.
- Department of Pharmacy, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, 221009, China.
- Department of Rheumatology and Immunology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, 221009, China.
- Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
- Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, 250355 China.
- School of Pharmaceutical Science, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240 Shanghai, China.
Zitieren
APA
Wei, J., Wu, Y., Chen, Y., He, Y., Raza, F., Zafar, H., Wang, T., Tian, T., Ge, L., Wu, Y., & Zheng, C. (2026). Mannose-targeted iguratimod liposomes in an HA-derived hydrogel: a synergistic therapy for rheumatoid arthritis via macrophage targeting and ROS scavenging. Biomaterials Science, 14(22), 5912-5926. https://doi.org/10.1039/d6bm00740f
Vancouver
Wei J, Wu Y, Chen Y, He Y, Raza F, Zafar H, et al. Mannose-targeted iguratimod liposomes in an HA-derived hydrogel: a synergistic therapy for rheumatoid arthritis via macrophage targeting and ROS scavenging. Biomaterials Science. 2026;14(22):5912-5926. doi:10.1039/d6bm00740f
BibTeX
@article{Wei2026,
author = {Wei, Jun and Wu, Yiqun and Chen, Yumei and He, Yangjingwan and Raza, Faisal and Zafar, Hajra and Wang, Ting and Tian, Tianli and Ge, Liang and Wu, Yunkai and Zheng, Chunli},
title = {Mannose-targeted iguratimod liposomes in an HA-derived hydrogel: a synergistic therapy for rheumatoid arthritis via macrophage targeting and ROS scavenging},
journal = {Biomaterials Science},
year = {2026},
volume = {14},
number = {22},
pages = {5912--5926},
doi = {10.1039/d6bm00740f}
}
EUVIMED